An open label, randomized control study for the comparison of effectiveness between biguanides and Dipeptidyl peptidase-4 (DPP-4) inhibitor in people with type 2 diabetes

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: biguanides Dipeptidyl peptidase‐4 inhibitor CONDITION: type 2 diabetes PRIMARY OUTCOME: The change of body composition ; WC, BW, the amount of fat,the amount of muscle mass, and so on INCLUSION CRITERIA: 1)Type 2 diabetes 2)HbA1c >=6.5% during 8 weeks prior to the study 3)Treated with none or single oral hypoglycemic agent or insulin over 12 weeks prior to the study
Epistemonikos ID: 0c56fd98f1fd112cf702df7e39cda24cd223ed6f
First added on: Aug 22, 2024